Krakow, Poland – November 26, 2020 – Pawel Przewiezlikowski, CEO at Ryvu Therapeutics, took part in the “Solebury Trout Talks”, a podcast which is part of the “Name Tag Series”, organized by Solebury Trout with an aim to introduce some of the most interesting figures from the world of biotech, finance and corporate development.

In an interview with Neil Canavan, Solebury Trout Scientific Advisor, Pawel Przewiezlikowski had the opportunity to tell about Ryvu’s beginning, milestones, and significant accomplishments, but also about his personal study and work experience, as well as the Polish market situation after 1989. The podcast is now available on Apple Podcasts and Google Podcasts: https://bit.ly/2JaWq6B